Total Payments
$169.17
2024 Payments
$16.41
Companies
7
Transactions
12
Medicare Patients
3,206
Medicare Billing
$221,580
Payment Breakdown by Category
Food & Beverage$169.17 (100.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $169.17 | 12 | 100.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Daiichi Sankyo Inc. | $42.44 | 3 | $0 (2022) |
| Lilly USA, LLC | $31.09 | 2 | $0 (2024) |
| Janssen Pharmaceuticals, Inc | $27.86 | 2 | $0 (2023) |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | $27.42 | 2 | $0 (2020) |
| AstraZeneca Pharmaceuticals LP | $14.72 | 1 | $0 (2018) |
| AbbVie, Inc. | $13.54 | 1 | $0 (2019) |
| Amgen Inc. | $12.10 | 1 | $0 (2018) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $16.41 | 1 | Lilly USA, LLC ($16.41) |
| 2023 | $14.01 | 1 | Janssen Pharmaceuticals, Inc ($14.01) |
| 2022 | $29.90 | 2 | Daiichi Sankyo Inc. ($29.90) |
| 2020 | $12.44 | 1 | Salix Pharmaceuticals, a division of Bausch Health US, LLC ($12.44) |
| 2019 | $55.74 | 4 | Salix Pharmaceuticals, a division of Bausch Health US, LLC ($14.98) |
| 2018 | $40.67 | 3 | AstraZeneca Pharmaceuticals LP ($14.72) |
All Payment Transactions
12 individual payment records from CMS Open Payments
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 01/09/2024 | Lilly USA, LLC | JARDIANCE (Drug), ZEPBOUND | Food and Beverage | In-kind items and services | $16.41 | General |
| Category: Diabetes | ||||||
| 09/26/2023 | Janssen Pharmaceuticals, Inc | XARELTO (Drug) | Food and Beverage | In-kind items and services | $14.01 | General |
| Category: Cardiovascular & Metabolism | ||||||
| 09/13/2022 | Daiichi Sankyo Inc. | INJECTAFER (Drug) | Food and Beverage | In-kind items and services | $14.95 | General |
| Category: Iron Deficiency Anemia | ||||||
| 03/03/2022 | Daiichi Sankyo Inc. | INJECTAFER (Drug) | Food and Beverage | In-kind items and services | $14.95 | General |
| Category: Iron Deficiency Anemia | ||||||
| 03/25/2020 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | XIFAXAN (Drug) | Food and Beverage | In-kind items and services | $12.44 | General |
| Category: GASTROENTEROLOGY | ||||||
| 09/23/2019 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | XIFAXAN (Drug) | Food and Beverage | In-kind items and services | $14.98 | General |
| Category: GASTROENTEROLOGY | ||||||
| 07/26/2019 | AbbVie, Inc. | Synthroid (Drug) | Food and Beverage | In-kind items and services | $13.54 | General |
| Category: Endocrinology | ||||||
| 06/03/2019 | Daiichi Sankyo Inc. | INJECTAFER (Drug) | Food and Beverage | In-kind items and services | $12.54 | General |
| Category: Anemia | ||||||
| 03/08/2019 | Lilly USA, LLC | EMGALITY (Drug) | Food and Beverage | In-kind items and services | $14.68 | General |
| Category: Neuroscience | ||||||
| 11/09/2018 | Janssen Pharmaceuticals, Inc | XARELTO (Drug), INVOKANA | Food and Beverage | In-kind items and services | $13.85 | General |
| Category: Cardiovascular & Metabolism | ||||||
| 03/01/2018 | AstraZeneca Pharmaceuticals LP | BYDUREON (Drug) | Food and Beverage | In-kind items and services | $14.72 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 01/29/2018 | Amgen Inc. | Repatha (Biological) | Food and Beverage | In-kind items and services | $12.10 | General |
| Category: Cardiology | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 8 | 302 | 310 | $57,172 | $19,355 |
| 2022 | 10 | 391 | 425 | $72,936 | $28,096 |
| 2021 | 12 | 998 | 1,043 | $187,325 | $74,207 |
| 2020 | 20 | 1,515 | 1,615 | $293,598 | $99,921 |
Total Patients
3,206
Total Services
3,393
Medicare Billing
$221,580
Procedure Codes
50
All Medicare Procedures & Services
50 procedure records from CMS Medicare Utilization — Page 1 of 2
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 95 | 100 | $25,000 | $6,679 | 26.7% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2023 | 56 | 56 | $14,000 | $4,582 | 32.7% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 33 | 34 | $8,500 | $3,151 | 37.1% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 21 | 21 | $5,775 | $2,829 | 49.0% |
| 87426 | Detection test by immunoassay technique for severe acute respiratory syndrome coronavirus | Office | 2023 | 28 | 28 | $1,680 | $969.36 | 57.7% |
| 71046 | X-ray of chest, 2 views | Office | 2023 | 26 | 27 | $1,377 | $764.80 | 55.5% |
| 87880 | Detection test by immunoassay with direct visual observation for streptococcus, group a (strep) | Office | 2023 | 18 | 18 | $450.00 | $291.60 | 64.8% |
| 81002 | Urinalysis, manual test | Office | 2023 | 25 | 26 | $390.00 | $88.66 | 22.7% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 104 | 114 | $28,500 | $8,658 | 30.4% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2022 | 87 | 87 | $21,750 | $8,095 | 37.2% |
| 87426 | Detection test by immunoassay technique for severe acute respiratory syndrome coronavirus | Office | 2022 | 74 | 77 | $4,620 | $3,297 | 71.4% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2022 | 23 | 23 | $6,325 | $3,207 | 50.7% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 24 | 24 | $6,000 | $2,897 | 48.3% |
| 87804 | Detection test by immunoassay with direct visual observation for influenza virus | Office | 2022 | 19 | 37 | $1,110 | $606.74 | 54.7% |
| 99212 | Established patient office or other outpatient visit, 10-19 minutes | Office | 2022 | 11 | 12 | $3,000 | $598.02 | 19.9% |
| 71046 | X-ray of chest, 2 views | Office | 2022 | 20 | 21 | $1,071 | $493.59 | 46.1% |
| 87880 | Detection test by immunoassay with direct visual observation for streptococcus, group a (strep) | Office | 2022 | 11 | 11 | $275.00 | $179.33 | 65.2% |
| 81002 | Urinalysis, manual test | Office | 2022 | 18 | 19 | $285.00 | $65.14 | 22.9% |
| 99203 | New patient outpatient visit, total time 30-44 minutes | Office | 2021 | 204 | 204 | $52,084 | $21,199 | 40.7% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Office | 2021 | 201 | 219 | $54,106 | $18,471 | 34.1% |
| 87426 | Elisa detection of severe acute respiratory syndrome coronavirus 2 (covid-19) antigen | Office | 2021 | 248 | 256 | $17,400 | $11,579 | 66.5% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 59 | 62 | $16,550 | $7,505 | 45.3% |
| 99202 | New patient outpatient visit, total time 15-29 minutes | Office | 2021 | 100 | 100 | $24,960 | $6,846 | 27.4% |
| 99204 | New patient outpatient visit, total time 45-59 minutes | Office | 2021 | 34 | 34 | $11,912 | $5,269 | 44.2% |
| 99212 | Established patient outpatient visit, total time 10-19 minutes | Office | 2021 | 23 | 24 | $5,873 | $1,313 | 22.4% |
About Dr. Gregory Carson, MD
Dr. Gregory Carson, MD is a Emergency Medicine healthcare provider based in Northfield, New Jersey. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 06/08/2006. The National Provider Identifier (NPI) number assigned to this provider is 1063452720.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Gregory Carson, MD has received a total of $169.17 in payments from pharmaceutical and medical device companies, with $16.41 received in 2024. These payments were reported across 12 transactions from 7 companies. The most common payment nature is "Food and Beverage" ($169.17).
As a Medicare-enrolled provider, Carson has provided services to 3,206 Medicare beneficiaries, totaling 3,393 services with total Medicare billing of $221,580. Data is available for 4 years (2020–2023), covering 50 distinct procedure/service records.
Ad
Practice Information
- Specialty Emergency Medicine
- Location Northfield, NJ
- Active Since 06/08/2006
- Last Updated 03/23/2023
- Taxonomy Code 207P00000X
- Entity Type Individual
- NPI Number 1063452720
Products in Payments
- INJECTAFER (Drug) $42.44
- XARELTO (Drug) $27.86
- XIFAXAN (Drug) $27.42
- JARDIANCE (Drug) $16.41
- BYDUREON (Drug) $14.72
- EMGALITY (Drug) $14.68
- Synthroid (Drug) $13.54
- Repatha (Biological) $12.10
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.